News

Podcast

A Close "Knit" Community

Author(s):

Jessica Skarzynski

In this week’s episode of CURE Talks Cancer, we spoke with Barbara Demorest, the founder of KnittedKnockers.org, about how her cancer journey helped her create a sense of community for women with breast cancer all around the world with Knitted Knockers.

After receiving a breast cancer diagnosis and being unable to have reconstructive surgery, Barbara Demorest was devastated. Then she discovered an alternative to traditional breast prosthetics that not only made her feel whole again, but changed her life, too.

In this week’s episode of CURE Talks Cancer, we spoke with Demorest, the founder of KnittedKnockers.org, about how her cancer journey helped her create a sense of community for women with breast cancer all around the world with Knitted Knockers.

For more information, visit KnittedKnockers.org.

Related Videos
Image of woman with blonde hair.
Image of woman with blonde hair.
Image of woman with brown hair.
a man and a woman in front of a dark blue background
a man and a woman in front of a dark blue background
a man and a woman in separate boxes in front of a dark blue background
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Related Content
Image of woman with hand on chest.
March 12th 2025

First Patients Enrolled in Trial on Anti-HER2 Therapy in HER2+ Breast Cancer

Spencer Feldman
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ breast cancer using circulating tumor DNA.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
green background with white text indicating FDA Approval, What You Need to Know
March 8th 2025

FDA Approves Biosimilars for Cancer-Related Skeletal Events

Alex Biese
The FDA has approved Stoboclo and Osenvelt to address skeletal issues faced by patients with cancer.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Illustration of a woman with red hair.
March 5th 2025

Becoming a Better Version of Me After Breast Cancer

Bonnie Annis
A revelation has given me perspective for the New Year, inspiring me to embrace change, set new goals and upgrade myself to a better version in 2025.
Image of woman holding pink ribbon.
March 4th 2025

Verzenio Combo May Improve Survival in HR+/HER2– Advanced Breast Cancer

Spencer Feldman
Verzenio plus Faslodex improved progression-free survival in HR+/HER2– advanced breast cancer after CDK/6i failure, with a manageable safety profile.